Christopher W Noel1,2,3, Rinku Sutradhar2,3, Haoyu Zhao3, Victoria Delibasic3, David Forner2,4, Jonathan C Irish5, Jonathan Kim6, Zain Husain6, Alyson Mahar7, Irene Karam6, Danny J Enepekides1,8, Kelvin K W Chan9, Simron Singh9, Julie Hallet2,3,8, Natalie G Coburn2,3,8, Antoine Eskander1,2,3,8. 1. Department of Otolaryngology-Head and Neck Surgery, University of Toronto, Toronto, Ontario, Canada. 2. Institute of Health Policy, Management and Evaluation, Dalla Lana School of Public Health, University of Toronto, Toronto, Ontario, Canada. 3. ICES, Toronto, Ontario, Canada. 4. Division of Otolaryngology-Head and Neck Surgery, Dalhousie University, Halifax, Nova Scotia, Canada. 5. Department of Surgical Oncology, Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada. 6. Department of Radiation Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 7. Department of Community Health Sciences, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada. 8. Department of Surgical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada. 9. Department of Medical Oncology, Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
Abstract
PURPOSE: To determine the association between patient-reported symptom burden and subsequent emergency department use and unplanned hospitalization (ED/Hosp) in a head and neck cancer (HNC) patient population. METHODS: This was a population-based study of patients diagnosed with HNC who had completed at least one outpatient Edmonton Symptom Assessment System (ESAS) assessment between January 2007 and March 2018 in Ontario, Canada. Logistic regression models were used to determine the relationship between outpatient ESAS scores and subsequent 14-day ED/Hosp use. A generalized estimating equation approach with an exchangeable correlation structure was incorporated to account for patient-level clustering. RESULTS: There were 11,761 patients identified, completing a total of 73,282 ESAS assessments and experiencing 5,203 ED/Hosp events. Six of the nine ESAS symptom scores were positively associated with ED/Hosp use, with pain, appetite, shortness of breath, and tiredness demonstrating the strongest associations. A global ESAS score was calculated by selecting the highest individual symptom score (h-ESAS). Among patients reporting a maximum h-ESAS score of 10, 15.1% had an ED/Hosp event within 14 days compared with 1.5% for those with the lowest possible score of zero. In adjusted analysis, the odds of ED/Hosp use increased with h-ESAS (1.23 per one-unit increase [95% CI, 1.22 to 1.25]). When treated as a categorical variable, patients with the maximum h-ESAS score of 10 had 9.23 (95% CI, 7.22 to 11.33) higher odds of ED/Hosp use, relative to the minimum score of zero. CONCLUSION: ESAS scores are strongly associated with subsequent ED/Hosp events in patients with HNC. Clinician education around how ESAS data might inform patient care may enhance symptom detection and management.
PURPOSE: To determine the association between patient-reported symptom burden and subsequent emergency department use and unplanned hospitalization (ED/Hosp) in a head and neck cancer (HNC) patient population. METHODS: This was a population-based study of patients diagnosed with HNC who had completed at least one outpatient Edmonton Symptom Assessment System (ESAS) assessment between January 2007 and March 2018 in Ontario, Canada. Logistic regression models were used to determine the relationship between outpatient ESAS scores and subsequent 14-day ED/Hosp use. A generalized estimating equation approach with an exchangeable correlation structure was incorporated to account for patient-level clustering. RESULTS: There were 11,761 patients identified, completing a total of 73,282 ESAS assessments and experiencing 5,203 ED/Hosp events. Six of the nine ESAS symptom scores were positively associated with ED/Hosp use, with pain, appetite, shortness of breath, and tiredness demonstrating the strongest associations. A global ESAS score was calculated by selecting the highest individual symptom score (h-ESAS). Among patients reporting a maximum h-ESAS score of 10, 15.1% had an ED/Hosp event within 14 days compared with 1.5% for those with the lowest possible score of zero. In adjusted analysis, the odds of ED/Hosp use increased with h-ESAS (1.23 per one-unit increase [95% CI, 1.22 to 1.25]). When treated as a categorical variable, patients with the maximum h-ESAS score of 10 had 9.23 (95% CI, 7.22 to 11.33) higher odds of ED/Hosp use, relative to the minimum score of zero. CONCLUSION: ESAS scores are strongly associated with subsequent ED/Hosp events in patients with HNC. Clinician education around how ESAS data might inform patient care may enhance symptom detection and management.
Authors: Christopher W Noel; Rinku Sutradhar; Lesley Gotlib Conn; David Forner; Wing C Chan; Rui Fu; Julie Hallet; Natalie G Coburn; Antoine Eskander Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-08-01 Impact factor: 8.961
Authors: Christopher W Noel; Yue Jennifer Du; Elif Baran; David Forner; Zain Husain; Kevin M Higgins; Irene Karam; Kelvin K W Chan; Julie Hallet; Frances Wright; Natalie G Coburn; Antoine Eskander; Lesley Gotlib Conn Journal: JAMA Otolaryngol Head Neck Surg Date: 2022-04-01 Impact factor: 8.961
Authors: Christopher W Noel; Antoine Eskander; Rinku Sutradhar; Alyson Mahar; Simone N Vigod; Elie Isenberg-Grzeda; James Bolton; Julie Deleemans; Wing C Chan; Ravleen Vasdev; Victoria Zuk; Barbara Haas; Stephanie Mason; Natalie G Coburn; Julie Hallet Journal: JAMA Netw Open Date: 2021-09-01
Authors: Adam Hubler; Daniel V Wakefield; Lydia Makepeace; Matt Carnell; Ankur M Sharma; Bo Jiang; Austin P Dove; Wesley B Garner; Drucilla Edmonston; John G Little; Esra Ozdenerol; Ryan B Hanson; Michelle Y Martin; Arash Shaban-Nejad; Maria Pisu; David L Schwartz Journal: Adv Radiat Oncol Date: 2022-07-30
Authors: Christopher W Noel; Sareh Keshavarzi; David Forner; Robert F Stephens; Erin Watson; Eric Monteiro; Ali Hosni; Aaron Hansen; David P Goldstein; John R de Almeida Journal: Otolaryngol Head Neck Surg Date: 2021-07-27 Impact factor: 5.591